# KCC2 phosphorylation dynamics relate to oligomerization during development and after spinal cord injury

**Authors:** Sylvie Liabeuf, Cecile Brocard, Jacques-Olivier Coq, Laurent Vinay, Frederic Brocard

PMC · DOI: 10.3389/fnmol.2026.1745037 · Frontiers in Molecular Neuroscience · 2026-02-04

## TL;DR

This study explores how phosphorylation of KCC2 affects its oligomerization during development and after spinal cord injury in rats.

## Contribution

The study identifies tyrosine dephosphorylation at the membrane as a key correlate of KCC2 oligomerization.

## Key findings

- KCC2 moves from the cytoplasm to the membrane during development with increased intracellular phosphorylation.
- Spinal cord injury shifts KCC2 phosphorylation toward lower oligomers and higher membrane tyrosine phosphorylation.
- DOI treatment partially reverses these effects, promoting oligomerization and developmental-like phosphorylation.

## Abstract

Effective synaptic inhibition relies on KCC2, a K+-Cl− cotransporter that forms oligomers to extrude chloride. However, how phosphorylation regulates oligomerization remains unclear. To address this, we studied the phosphorylation of KCC2 in the lumbar spinal cord of neonatal rats by subcellular fractionation and phospho-specific western blotting across three paradigms with distinct expression profiles: developmental upregulation, spinal cord injury (SCI)-induced downregulation, and pharmacological rescue with the 5-HT2A/2C agonist DOI. KCC2 moved from cytoplasm to membrane during development, exhibiting increased intracellular phosphorylation at serine, threonine, and tyrosine residues and decreased membrane tyrosine phosphorylation as a result of the oligomer formation. SCI caused a shift in this ratio in favor of lower oligomers, higher membrane tyrosine phosphorylation and lower intracellular threonine phosphorylation. DOI partially reversed these deficits, reinforcing oligomerization and adapting phosphorylation to a developmental profile. In sum, this study identifies tyrosine dephosphorylation at the membrane as a reliable correlate of oligomerization and offers a unified quantitative model for the regulation of KCC2 in development, after injury, and upon pharmacological rescue.

## Linked entities

- **Genes:** SLC12A5 (solute carrier family 12 member 5) [NCBI Gene 57468]
- **Chemicals:** DOI (PubChem CID 1229)
- **Diseases:** spinal cord injury (MONDO:0043797)

## Full-text entities

- **Genes:** Mb (myoglobin) [NCBI Gene 59108] {aka Glng}, Slc12a5 (solute carrier family 12 member 5) [NCBI Gene 171373] {aka Kcc2}, Prkcg (protein kinase C, gamma) [NCBI Gene 24681] {aka PKC, PKCI, Prkc, Prkcc, RATPKCI}, Bdnf (brain-derived neurotrophic factor) [NCBI Gene 24225], Sumo1 (small ubiquitin-like modifier 1) [NCBI Gene 301442], Slc12a5 (solute carrier family 12, member 5) [NCBI Gene 57138] {aka KCC2, mKIAA1176}, Slc12a2 (solute carrier family 12 member 2) [NCBI Gene 83629] {aka Bsc2, Nkcc1}, Serpina5 (serpin family A member 5) [NCBI Gene 65051] {aka Pci}, Ntrk2 (neurotrophic receptor tyrosine kinase 2) [NCBI Gene 25054] {aka RATTRKB1, TRKB1, Tkrb, trk-B, trkB}
- **Diseases:** chloride dysregulation (MESH:D021081), hyperreflexia (MESH:D012021), SCI (MESH:D013119), spinal cord dysfunction (MESH:D013118), weight gain (MESH:D015430), neuropathic pain (MESH:D009437), weight loss (MESH:D015431), hypothermia (MESH:D007035), injury (MESH:D014947), spasticity (MESH:D009128)
- **Chemicals:** buprenorphine (MESH:D002047), GABA (MESH:D005680), DTT (MESH:D004229), SDS (MESH:D012967), PVDF (MESH:C024865), glutamic acid (MESH:D018698), serotonin (MESH:D012701), amoxicillin (MESH:D000658), povidone-iodine (MESH:D011206), 2,5-dimethoxy-4-iodoamphetamine hydrochloride (MESH:C015952), Thr (MESH:D013912), glycine (MESH:D005998), chloride (MESH:D002712), calcium (MESH:D002118), pSer (MESH:D010768), Tyr (MESH:D014443), prochlorperazine (MESH:D011346), sucrose (MESH:D013395), sodium pyrophosphate (MESH:C003319), iodoacetamide (MESH:D007460), sodium fluoride (MESH:D012969), aspartic acid (MESH:D001224), Igepal CA-630 (MESH:C010615), phosphotyrosine (MESH:D019000), Ser (MESH:D012694), Cl (MESH:D002713), phosphothreonine (MESH:D010769), Ca2+ (-), NaCl (MESH:D012965), sodium vanadate (MESH:D014638), disulfide (MESH:D004220), sodium phosphate (MESH:C018279)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12913098/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12913098/full.md

## References

90 references — full list in the complete paper: https://tomesphere.com/paper/PMC12913098/full.md

---
Source: https://tomesphere.com/paper/PMC12913098